The United States Patent and Trademark Office (USPTO) has published an intent-to-use trademark application for the mark RENASENSE. The application, filed on March 20, 2026, specifically covers a range of medical instruments and devices. These include glucose meters, blood glucose meters, devices for monitoring blood glucose, electrochemical sensors for medical fluid analysis, and patient monitors for measuring analyte concentrations such as sodium ion, potassium ion, and glucose levels in blood or interstitial fluid.

This filing represents a new trademark application for goods within Class 010, which pertains to medical instruments. While this is a trademark application and not a regulatory rule, it indicates a potential new market entrant or product line in the medical device sector. Compliance officers in the medical device and pharmaceutical industries should note this application as it may signal future product launches or competitive activity in areas related to blood glucose monitoring and analyte measurement.